Baillie Gifford & Co’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $128M | Buy |
|
|||||
|
2019
Q4 | $244M | Sell |
|
|||||
|
2019
Q3 | $265M | Sell |
|
|||||
|
2019
Q2 | $265M | Sell |
|
|||||
|
2019
Q1 | $317M | Buy |
|
|||||
|
2018
Q4 | $276M | Sell |
|
|||||
|
2018
Q3 | $439M | Buy |
|
|||||
|
2018
Q2 | $353M | Sell |
|
|||||
|
2018
Q1 | $283M | Sell |
|
|||||
|
2017
Q4 | $331M | Buy |
|
|||||
|
2017
Q3 | $348M | Sell |
|
|||||
|
2017
Q2 | $250M | Sell |
|
|||||
|
2017
Q1 | $191M | Sell |
|
|||||
|
2016
Q4 | $169M | Sell |
|
|||||
|
2016
Q3 | $215M | Sell |
|
|||||
|
2016
Q2 | $346M | Sell |
|
|||||
|
2016
Q1 | $425M | Buy |
|
|||||
|
2015
Q4 | $488M | Buy |
|
|||||
|
2015
Q3 | $401M | Buy |
|
|||||
|
2015
Q2 | $353M | Buy |
|
|||||
|
2015
Q1 | $351M | Buy |
|
|||||
|
2014
Q4 | $329M | Buy |
|
|||||
|
2014
Q3 | $347M | Buy |
|
|||||
|
2014
Q2 | $342M | Buy |
|
|||||
|
2014
Q1 | $296M | Buy |
|
|||||
|
2013
Q4 | $95.4M | Buy |
|
|||||
|
2013
Q3 | $86.1M | Buy |
|